In April 2026, Gyre initiated its adaptive Phase 2/3 clinical trial in oncology-related pulmonary complications, with the first patient enrolled. The trial is evaluating pirfenidone for ...

ACM Research, Inc. ('ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced ...

Donald Trump's team believes it is 'closest' it has ever been to a peace deal with Iran, which would reportedly see both ...

And check out SPRING HERB SALE Lyman Estate Greenhouses on the Waltham Patch calendar ...

Trumpeter Rob Dehlinger’s throwback, high-energy retro act transports its audiences to smoky, mid-20th century nightclubs.